Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1408_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
Note: Page numbers followed by f indicate figures and t indicate tables.
A
AAF. See Anal advancement flap (AAF)
AAST. See American Association for the Surgery
of Trauma (AAST)
Abscess
anorectal (see Anorectal abscess)
perianal, in Crohn’s disease, 142–147
diagnosis of, 145
imaging of, 145–146
treatment for, 146–147
Acellular dermal matrix (ADM), 94
Acellular extracellular matrix (AEM), 94
Adalimumab, for perianal abscess and fistula
in Crohn’s disease, 146
Adipose-derived stem cells (ASC)
for anorectal abscess, 94
for anorectal fistula, 94
ADM. See Acellular dermal matrix (ADM)
Advanced Trauma Life Support (ATLS),
208–210
Advancement flap
for anorectal abscess, 91–92, 92f
for anorectal fistula, 91–92, 92f
AEM. See Acellular extracellular matrix (AEM)
AFP. See Anal fistula plug (AFP)
AGA. See American Gastroenterological
Association (AGA)
Albendazole, for pinworm pruritus, 121
Altemeier operation, 255
Amebiasis, 132–133
American Association for the Surgery of
Trauma (AAST)
rectal injury grading system of hematoma,
208t
American Gastroenterological Association
(AGA)
classification of perianal fistula, 144, 144t
Amitriptyline, for fecal incontinence, 171
Amussat, 29
Anal adenocarcinoma, 193
Anal advancement flap (AAF), for anal fissure,
75–76
Anal basal cell carcinoma, 196
Anal Buschke-Loewenstein tumor, 192
Anal carcinogenesis, 190–191
Anal-closure mechanism
anal-closure mechanism, functional
assessment of, 24–25, 24f
functional assessment of, 24–25, 24f
in humans, anatomy and function
assessment of, 21–23, 23f
Anal fissure
additional investigations for, 67, 68–71f
definition of, 65, 66f
diagnosis of, 66
–67
etiology
of,
65–66
pathophysiology of, 65–66
practical therapeutical guideline and
work-up, 76
and pruritus ani, 119–120, 120t
specific conditions, 77
human immunodeficiency virus, 77
inflammatory bowel disease, 77
lues, 77
after surgery for anorectal diseases, 253
symptoms of, 66–67
therapy for, 67–76
conservative management, 72–75
surgical management, 75–76
Anal fistula plug (AFP)
for anorectal abscess, 93
for anorectal fistula, 93
Analgesics, for hemorrhoids, 119
Anal lymphoma, 195
Anal mass sensation, 194
Anal melanoma, 194–195
265

Anal MEPs, 42
Anal mesenchymal tumors, 195–196
Anal neuroendocrine tumors, 195
Anal plugs, for fecal incontinence, 172
Anal radiofrequency, for fecal incontinence,
173
Anal sexual intercourse, 191
Anal squamous cell carcinoma (SCC), 189
Anal squamous intraepithelial lesions, 189–191
Anal stricture, following a Milligan-Morgan
operation, 252f
Anal tattooing, for pruritus ani, 118
Anal tumors, 189
anal adenocarcinoma, 193
anal basal cell carcinoma, 196
anal Buschke-Loewenstein tumor, 192
anal lymphoma, 195
anal melanoma, 194–195
anal mesenchymal tumors, 195–196
anal neuroendocrine tumors, 195
anal SCC, 191–192
anal squamous intraepithelial lesions,
189–191
extramammary Paget disease, 193–194
secondary tumors (metastases), anal canal,
196
Anocutaneous reflex assessment, 32
Anodermal advancement flap, 91–92, 92f
Anoplasty, for anorectal malformations,
181–183, 184f
Anorectal abscess
adipose-derived stem cells, 94
classification of, 82–83, 82f
clinical presentation of, 83–84
in Crohn’s disease patients, treatment for,
95–97
laser ablation for, 95
nonsphincter-preserving operation, 90–91
fistulectomy, 90
fistulotomy, 90
seton, 90–91
over-the-scope-clip, 94–95
preoperative imaging of, 85–88, 86–87f
sphincter-preserving operation, 91–95, 96f
advancement flap, 91–92, 92f
anal fistula plug, 93
fibrin glue injection, 92
ligation of intersphincteric fistula tract, 93
video-assisted ablation of the fistula tract,
94
treatment for, 88–89
Anorectal anatomy and function
anal-closure mechanism in humans,
anatomy and function assessment of,
21–23, 23f
deep pelvic floor muscles (levator ani)
anatomy and function, relationship
between, 14–17, 15–19f, 19–
20
external
anal
sphincter, 11–13, 12–13f
length-tension function of, 20, 21f
internal anal sphincter, 10–11, 10f
neural control of, 11
puborectalis muscle, 14–17
length-tension function of, 20, 21f
Anorectal angle, 154–156, 158
Anorectal diseases, and pruritus ani, 118–121
anal fissure, 119–120, 120t
hemorrhoids, 118–119
infections, 120–121
psychological causes, 121
Anorectal disorders (ADs), diagnostic tools in,
38f
anal MEPs, 42
anorectal sensory and motor function tests,
42–44
balloon distension and rectal barostat,
42–44, 43f
anorectal structure tests, 42
endoanal and pelvic floor ultrasound, 42
evacuation tests, 44–45
balloon expulsion test, 44
colonic transit testing, 44–45
defecography, 45
initial approach, 38–39
motor function tests, 39–42
anorectal manometry, 39–41
anorectal neurophysiology, 41
functional lumen imaging probe, 41
translumbar MEPs, 42
transsacral MEPs, 42
266 Index

Anorectal fistula (ARF)
adipose-derived stem cells, 94
classification of, 82–83, 84f
clinical presentation of, 83–84
in Crohn’s disease patients, treatment for,
95–97
laser ablation for, 95
nonsphincter-preserving operation, 90–91
fistulectomy, 90
fistulotomy, 91f
seton, 90–91, 91f
over-the-scope-clip, 94–95
preoperative imaging of, 85–88, 86–87f
sphincter-preserving operation, 91–95, 96f
advancement flap, 91–92, 92f
anal fistula plug, 93
fibrin glue injection, 92
ligation of intersphincteric fistula tract, 93
video-assisted ablation of the fistula
tract, 94
treatment for, 89–95
Anorectal foreign body
body packer, 207
body pusher, 207
clinical assessment of, 202–203
history taking, 202
physical examination, 202–203
radiologic evaluation, 203
epidemiology of, 201–202
ingested foreign body, 207
management of, 203–206, 206f
endoscopic removal, 204 –205
minimally invasive transanal removal, 205
operative removal, 205–206
transanal removal, 203–204
type of, 202t
Anorectal function assessment, using
meneuvers, 32–33
Anorectal junction (ARJ), 154, 156–158
Anorectal malformations
classification of, 179, 180t
clinical manifestations and diagnostic
approach, 180–182, 181–182f
follow-up, 185–186
rectovestibular fistula, 179, 180f
treatment for, 183–185
medical approach, 183
surgical approach, 183–185, 184–
186f
Anor
ectal
manometry (ARM), 34–35, 218,
256–257
for evacuatory dysfunction, 40–41, 40f
for fecal incontinence, 39–40, 165–167, 167f
for motor function tests, 39–41
Anorectal neurophysiology, for anorectal
disorders, 41
Anorectal pain assessment, using maneuvers,
33–34
Anorectal region examination
clinical utility of DRE, 34–35
DRE protocol, 29–34, 30f, 31t
Anorectal sensory tests, 42–44
balloon distension and rectal barostat,
42–44, 43f
Anorectal structure tests, 42
endoanal and pelvic floor ultrasound, 42
Anorectal trauma/injury, 208–209
clinical assessment of, 208–209
grading system of, 208t
Anorectum, embryology of
hindgut, 2–3, 4f
theories on development of hindgut, 3–6
Antegrade continence enema, for fecal
incontinence, 173
Anterograde enemas, 224
Antibiotic therapy, for anorectal abscess, 89
Anticoagulants, hemorrhoids in patients
taking, 60–61
Antiplatelet drugs, hemorrhoids in patients
taking, 54
Antiprolapse surgery, 232–233
Apoptosis, 5–6
ARF. See Anorectal fistula (ARF)
Aristotle, 179
ARJ. See Anorectal junction (ARJ)
ARM. See Anorectal manometry (ARM)
Artificial intestinal sphincter, for fecal
incontinence, 174
ASC. See Adipose-derived stem cells (ASC)
ATLS. See Advanced Trauma Life Support
(ATLS)
Index 267

Autologous adipose tissue transplantation, for
anal fissure, 76
Azathioprine, for perianal abscess and fistula
in Crohn’s disease, 146
B
Balloon distension, 42–44, 43f
Balloon expulsion test (BET ), 44
Barium defecography, 45, 218
Barium enema, 231
Bascom I technique, 106, 108f
Bascom II technique, 106, 110
Benign perineal teratoma, 181f
BET. See Balloon expulsion test (BET)
BFT. See Biofeedback therapy (BFT)
Bioabsorbable synthetic fistula plug, 93
Biofeedback therapy (BFT)
for fecal incontinence, 171–172
pelvic floor retraining, 219–222
pelvic floor therapy with, for anal fissure, 72
Biologic sealant, for pilonidal disease, 111
Body packers, 207
Body pushers, 207
Body stuffing, 207
Botulinum toxin (BT), 219–222
for anal fissure, 74–75
BT. See Botulinum toxin (BT)
Bucket-handle malformation, 181, 184f
C
Calcium blockers ointment, for anal fissure,
67–72
Calcium channel blockers (CCB), for anal
fissure, 74–77
Calcium dobesilate, for internal hemorrhoids,
57
Capsaicin, for pruritus ani, 117–118
Cardiff classification, of perianal disease, 139t
CCB. See Calcium channel blockers (CCB)
CDC. See Centers for Disease Control and
Prevention (CDC)
Ceftriaxone/azithromycin, for gonorrhea, 128
Ceftriaxone, for gonorrhea, 128
Centers for Disease Control and Prevention
(CDC), STDs treatment guidelines, 127
Cervical carcinogenesis, 190–191
Chemical sphincterotomy, for anal fissure,
72–74
Chemotherapy, 192
Chronic constipation, 215–216
Chronic proctalgia (CP), 237
Cicatrization, for pilonidal disease, 105–106
Ciprofloxacin, for perianal abscess and fistula
in Crohn’s disease, 146
Cirrhosis patients, hemorrhoids in, 62
Cloaca, 2–3, 5
Coccygodynia, 246–247
Colonic transit testing, 44– 45, 218
Colostomy
for anorectal malformations, 181–183, 184f
for fecal incontinence, 174
Computed tomography (CT) scan
for anorectal abscess, 86–88
for anorectal fistula, 86–
88
for
anorectal
foreign body, 203
for anorectal trauma/injury, 208–209
Constipation, 215
clinical evaluation, 217
functional testing, 217–218
pathophysiology, 216
therapeutic management, 218–224
treatment options for, 222–224
Conventional fistulography, for anorectal
fistula, 85
Corticosteroids, for hemorrhoids, 119
Crohn’s disease (CD)
patients
ARA/ARF treatment in, 95–97
hemorrhoids in, 61
perianal (see Perianal Crohn’s disease, in IBD
patients)
Cryosurgical ablation, for pilonidal disease, 110
Cryotherapy, for internal hemorrhoids, 60
Cryptoglandular theory, 81
CT. See Computed tomography (CT) scan
Cytomegalovirus (CMV) and infectious
proctitis, 131–132
D
Deep pelvic floor muscles, 14–17, 15–19f
anatomy and function, relationship
between, 19–20
268 Index

Defecatory disorders, 216
treatment options for, 219–222
Defecography, 45, 230–231
for fecal incontinence, 169
for pelvic floor disorders, 153–155
magnetic resonance, 155–156
normal findings, 155
parameters, 154
technique, 154
Delorme operation, 255
Descending perineum syndrome, ultrasound
for, 157–158
Diagnosis, SRUS, 228–231
anorectal function tests, 231
histology, 230
radiology, 230–231
Dietary modification, for internal
hemorrhoids, 41
Digestive system, development of, 2f
Digital palpation, 32
Digital rectal examination (DRE)
for anorectal dysfunction, 38–39
for anorectal foreign body, 202–203
clinical utility of, 34–35
components of, 31t
protocol, 29–34, 30f
digital palpation, 32
inspection, 32
perineal sensation and anocutaneous
reflex assessments, 32
using maneuvers, 32–34
Diltiazem, for anal fissure, 74
Diosmin, for internal hemorrhoids, 57
Distal colostogram, for anorectal
malformations, 182–183, 182f, 185f
Doppler-guided hemorrhoidal arterial
ligation, for grade II–III hemorrhoids,
59–60
Doxycycline, for gonorrhea, 128
for pelvic floor disorders, 153–155
DRE scoring system (DRESS), 34
DRE. See Digital rectal examination (DRE)
DRESS. See DRE scoring system (DRESS)
Dynamic graciloplasty, for fecal incontinence,
174
Dyssynergic defecation, 215–217
E
EAS. See External anal sphincter (EAS)
EAUS. See Endoanal ultrasound (EAUS)
ED. See Evacuatory dysfunction (ED)
Electromyography (EMG), for anorectal
disorders, 41
Embryology, of anorectum. See Anorectum,
embryology of
Embryonic cell differentiation, 5
EMG. See Electromyography (EMG)
Endoanal ultrasonography, 230
Endoanal ultrasound (EAUS), 42
for
anal
fissure, 70–71f
for anorectal abscess, 85–86
for anorectal fistula, 85–86, 86–87f, 88
for fecal incontinence, 168, 169f
for perianal fistula in Crohn’s disease,
145–146
EndoFLIP, for anorectal disorders, 41
Endoscopic removal, for mendoscopic
removal, 204–205
Endothelin-1, for internal hemorrhoids, 56
Enemas, 223–224
Enterobius vermicularis (pinworms), and
pruritus ani, 120–121
Enterocele, ultrasound for, 157
Evacuation tests, 44–45
balloon expulsion test, 44
colonic transit testing, 44–45
defecography, 45
Evacuatory dysfunction (ED)
anorectal manometry for, 40–41, 40f
balloon distension for, 42–43
balloon expulsion test for, 44
colonic transit testing for, 44–45
defecography for, 45
pelvic floor ultrasound for, 42
External anal sphincter (EAS), 9–13, 13f, 41, 156
anal fissure in, 66f
endoanal ultrasound for, 42
and fecal incontinence, 162
length-tension function of, 20, 21f
muscle fibers of, 12f, 13
External hemorrhoids, 53f
complications of, 55
management of, 55
Index 269

External rectal prolapse surgery, 255, 255f
Extramammary Paget disease, 193–194
Extrasphincteric fistula, 83
F
FB. See Foreign body (FB)
Fecal incontinence (FI), 29, 34
anorectal manometry for, 39–40
balloon distension for, 42–44
classification of, 161
defined, 9–10, 161
diagnosis of, 164–169
clinical evaluation, 164–165
diagnostic tests, 165–167, 166t, 167f
rectal sensory testing, 168–169, 169f
endoanal ultrasound for, 42
etiology of, 9–10
and external anal sphincter, 13
in IBD patients with perianal Crohn’s
disease, 147
pathophysiology of, 162–164, 163t
alterations in stool characteristics, 164
anal sphincter, 162
neurologic alterations, 162–163
pelvic floor muscle injury, 162
sensory alterations, 164
treatment for, 169–175, 170f
minimally invasive treatments, 172–174
noninvasive treatments, 169–172
Fiber-enriched diet, for anal fissure, 72–75
Fiber supplements, for fecal incontinence, 171
Fibrin glue injection
for anorectal abscess, 92
for anorectal fistula, 92
FiLaC. See Fistula-tract laser closure (FiLaC)
FI. See Fecal incontinence (FI)
Fissure
anal (see Anal fissure)
perianal, in Crohn’s disease
clinical features, 141
treatment, 141–142
Fissurectomy, for anal fissure, 76
Fistula
anal, after surgery for anorectal diseases,
253, 254f
anorectal (see Anorectal fistula (ARF))
extrasphincteric, 83
fourchette, 181f
intersphincteric, 82–83
perianal, in Crohn’s disease, 142–147
classification of, 143–144, 143–
144t
diagnosis
of,
145
imaging of, 145–146
treatment for, 146–147, 148f
rectovestibular, 179, 180f
subcutaneous, 83
suprasphincteric, 83
transphincteric, 82
Fistula-tract laser closure (FiLaC), 95
Fistulectomy
for anorectal abscess, 90
for anorectal fistula, 90
Fistulotomy
anal incontinence and soiling after, 259
for anorectal abscess, 89–90
for anorectal fistula, 90
Flavonoids, for internal hemorrhoids, 57
FLIP. See Functional lumen imaging probe
(FLIP)
Fluorescent Treponemal Antibody Absorption
(FTA-ABS) test, for syphilis, 129
Foley catheter, 42–43
Foregut, 1
Foreign body (FB), anorectal. See Anorectal
foreign body
Foscarnet, for CMV proctitis, 132
Fourchette fistula, 181f
FTA-ABS. See Fluorescent Treponemal
Antibody Absorption (FTA-ABS)
Functional anorectal pain, 238–243
clinical presentation, 240
definition, 238
diagnostic tests, 240–241
epidemiology, 238–239
management, 241–243
pathophysiology, 239–240
predisposing conditions, 239–240
Functional disorders after surgery for anorectal
diseases, 251–256
anal fissure, 253
anal fistulas, 253, 254f
external rectal prolapse surgery, 255, 255f
270 Index

hemorrhoids, 251–252, 252–253f
imperforate anus surgery, 255, 256f
obstructed defecation syndrome, 253–255,
254f
rectal cancer surgery, 256
Functional lumen imaging probe (FLIP), 9–10,
24–25
for anorectal disorders, 41
G
Ganciclovir, for CMV proctitis, 132
Gastrointestinal stromal tumors (GISTs),
195–196
Glyceryl trinitrate (GTN), for anal fissure,
67–75
Gonorrhea, and infectious proctitis, 127–128
Goodsall’s rule, 85
GTN. See Glyceryl trinitrate (GTN)
H
HD-ARM. See High-resolution anorectal
manometry (HD-ARM)
Hemorrhoidal disease
classification of, 53, 53f
clinical evaluation of, 54–55
external hemorrhoids, complications of, 55
external hemorrhoids, management of, 55
internal hemorrhoids, management of,
55–60
dietary and lifestyle modification, 41
office-based procedures, 60
oral medication, 57
rubber band ligation, 58–60, 59f
sclerotherapy, 57–58, 58f
topical medication, 56
management in specific considerations,
60–62
cirrhosis and portal hypertension, 62
Crohn’s disease patients, 61
immunocompromised patients, 61
patients taking anticoagulants or
antiplatelet drugs, 60–61
pregnancy, 61
pathophysiology of, 52
prevalence of, 51–52
risk factors of, 51–52
Hemorrhoidectomy, 119
anal incontinence and soiling after, 259
obstructed defecation for anal structure
after, 260
Hemorrhoids
in perianal Crohn’s disease patients, 140
and pruritus ani, 118–119
after surgery for anorectal diseases, 251 –252,
252–253f
Herpes simplex virus (HSV ) and infectious
proctitis, 125–127, 127f
Hesperidin, for internal hemorrhoids, 57
High-resolution anorectal manometry
(HD-ARM), for evacuatory dysfunction,
40–41
Hig
h-resolution
anorectal manometry
(HR-ARM), 24–25, 24f
Hindgut, 1
embryology of, 2–3, 4f
theories on development of, 3–6
HIV. See Human immunodeficiency virus
(HIV)
HMO system, 156
HR-ARM. See High-resolution anorectal
manometry (HR-ARM)
HSIL, 191
HSV. See Herpes simplex virus (HSV )
Human immunodeficiency virus (HIV ) and
anal fissure, 77
Humans, anal-closure mechanism in
anatomy and function assessment of,
21–23, 23f
I
IAS. See Internal anal sphincter (IAS)
IBD. See Inflammatory bowel disease (IBD)
Idiopathic pruritus ani, 116
Ileostomy, for fecal incontinence, 174
Immunocompromised patients, hemorrhoids
in, 61
Imperforate anus surgery, 255, 256f
Infections, and pruritus ani, 120–121
Infectious proctitis
amebiasis, 132–133
causes of, 126t
cytomegalovirus and, 131–132
Index 271

Infectious proctitis (Continued)
defined, 125
gonorrhea and, 127–128
herpes simplex virus and, 125–127, 127f
lymphogranuloma venereum and, 130–131
non-LGV chlamydia and, 130
syphilis and, 128–130, 129f
Inflammatory bowel disease (IBD)
and anal fissure, 77
anorectal abscess and, 81
anorectal fistula and, 81, 89
patients, perianal Crohn’s disease in
(see Perianal Crohn’s disease, in IBD
patients)
Infliximab, for perianal abscess and fistula in
Crohn’s disease, 146
Infrared coagulation, for internal
hemorrhoids, 60
Ingested foreign body, 207
Internal anal sphincter (IAS), 10–11, 10f, 156
anal fissure in, 65, 66f, 67, 74
endoanal ultrasound for, 42
and facal incontinence, 162
neural control of, 11
Internal hemorrhoids, 53, 53f
grades of, 54f
management of, 55–60
dietary and lifestyle modification, 56
oral medication, 57
rubber band ligation, 58–60, 59f
sclerotherapy, 57–58, 58f
topical medication, 56
International Anorectal Physiology Working
Group (IAPWG), 218
Intersphincteric fistula, 82–83
Intersphincteric injections, for fecal
incontinence, 173–174
Intussusception
obstructed defecation after stapled
hemorrhoidopexy or STARR operation
for, 260
rectal mucosal, assessment using
maneuvers, 33–34
rectal, ultrasound for, 156
ISDN. See Isosorbide dinitrate (ISDN)
Isosorbide dinitrate (ISDN), for anal
fissure, 74
Itchy anus. See Pruritus ani
K
Karydakis technique, 106, 107f
L
LARS. See Low anterior resection syndrome
(LARS)
LAS. See Levator ani syndrome (LAS)
Laser ablation
for anorectal abscess, 95
for anorectal fistula, 95
Laser depilation, for pilonidal disease, 110
Laser therapy, for internal hemorrhoids, 60
Lateral internal sphincterotomy (LIS)
for anal fissure, 67–72, 74–76
anal incontinence and soiling after, 259
Laxatives, for anal fissure, 72–75
Length-tension
function,
of EAS and PRM, 20,
21f
Levator ani syndrome (LAS), 14–17, 15–19f, 238
anatomy and function, relationship
between, 19–20
LGV. See Lymphogranuloma venereum (LGV)
Lidamidine, for fecal incontinence, 171
Lifestyle modification, for internal
hemorrhoids, 56
LIFT. See Ligation of intersphincteric fistula
tract (LIFT)
Ligation of intersphincteric fistula tract (LIFT)
for anorectal abscess, 93
for anorectal fistula, 93
Limberg flap technique, 109
Liquid paraffin (mineral oil), 223
LIS. See lateral internal sphincterotomy (LIS)
Loperamide, for fecal incontinence, 171
Low anterior resection syndrome (LARS), 256,
260
Lues, and anal fissure, 77
Lumbosacral spine X-ray, for anorectal
malformations, 182
Lymphogranuloma venereum (LGV ) and
infectious proctitis, 130–131
Lymphoid tissue, 195
272 Index

M
Magnetic anal sphincter (Fenix), for fecal
incontinence, 175
Magnetic resonance diffusion tensor imaging
(MRDTI), of external anal sphincter,
12–13, 14f
Magnetic resonance imaging (MRI)
for anal sphincter, 42
for anorectal abscess, 86–88
for anorectal fistula, 86–88
for fecal incontinence, 169
for perianal fistula in Crohn’s disease,
145–146
Malone procedure, for fecal incontinence, 173
Maneuvers
anorectal function assessment using, 32–33
anorectal pain assessment using, 33–34
rectal mucosal intussusception assessment
using, 33–34
rectocele assessment using, 33–34
Marsupialization, for pilonidal disease,
105–106, 106f
MDSCs. See muscle-derived stem cells
(MDSCs)
Mebendazole, for pinworm pruritus, 121
6-Mercaptopurine, for perianal abscess and
fistula in Crohn’s disease, 146
Mesenchymal stem cells (MSCs), 94
local injection of, for perianal abscess and
fistula in Crohn’s disease, 147
Mesoderm, 1–3
Metronidazole
for amebiasis, 133
for perianal abscess and fistula in Crohn’s
disease, 146
Micro CT imaging, of external anal sphincter,
12–13
Midgut, 1
Minimally invasive transanal removal,
anorectal foreign body, 205
Mixed hemorrhoids, 53f
MLCK. See Myosin light chain through a kinase
(MLCK)
Motor-evoked potentials (MEPs)
anal, 42
translumbar, 42
transsacral, 42
Motor function tests, for anorectal disorders,
39–44
translumbar MEPs, 42
MRD. See MRI defecography (MRD)
MRDTI. See Magnetic resonance diffusion
tensor imaging (MRDTI)
MRI defecography (MRD), 45
or pelvic floor disorders, 155–156
parameters and normal findings, 155–156
technique, 155
MRI. See Magnetic resonance imaging (MRI)
MSCs. See Mesenchymal stem cells (MSCs)
Mucosal advancement flap, 91–92, 92f
Muscle-derived stem cells (MDSCs), for fecal
incontinence,
175
M
yGiHealth, 9–10
Myosin light chain through a kinase
(MLCK), 10–11
N
NAATs. See Nucleic acid amplification tests
(NAATs)
Neural control of internal anal sphincter, 11
Neurogenic itch, 115
Neuropathic itch, 115
Nifedipine, for anal fissure, 74
Nitrates, for anal fissure, 72
Nitroglycerine (NTG), 76
Non-LGV chlamydia, for syphilis, 130
NTG. See nitroglycerine (NTG)
Nucleic acid amplification tests (NAATs), for
gonorrhea, 128–131
O
OASIS. See Obstetric anal sphincter injuries
(OASIS)
Obstetric anal sphincter injuries (OASIS), 42
Obstructed defecation
for anal structure after hemorroidectomy,
260
after stapled hemorrhoidopexy or STARR
operation for rectocele/
intussusception, 260
Index 273

Obstructed defecation syndrome, after surgery
for anorectal diseases, 253–255, 254f
Operative removal, of anorectal foreign body,
205–206
Opioid-induced constipation, 223
Oral medication, for internal hemorrhoids, 57
Osmotic laxatives, 222–223
Overlapping sphincteroplasty, for fecal
incontinence, 174
Over-the-scope-clip
for anorectal abscess, 94–95
for anorectal fistula, 94–95
P
Parks classification, of perianal fistula, 143,
143t
Paromomycin, for amebiasis, 133
PCDAI. See Perianal Crohn’s Disease Activity
Index (PCDAI)
PCL. See Pubococcygeal line (PCL)
Pelvic floor disorders, imaging of
defecography, 153–155
normal findings, 155
parameters, 154
technique, 154
MR defecography, 155–156
parameters and normal findings, 155–156
technique, 155
ultrasound, 156
descending perineum syndrome, 157–158
enterocele and sigmoidocele, 157
intussusception and rectal prolapse, 156,
157f
rectocele, 157, 158f
spastic pelvic floor syndrome, 158
Pelvic floor muscle injury, and fecal
incontinence, 162
Pelvic floor therapy, for anal fissure, 72–75, 73f
Pelvic floor ultrasound, for anorectal disorders,
42
Pen˜a, Alberto, 179
Perianal Crohn’s Disease Activity Index
(PCDAI), 145t
Perianal Crohn’s disease, in IBD patients
classification of, 138–149
abscess, 142–147
Cardiff classification, 139t
complications after restorative
proctocolectomy, 147–149
fecal incontinence, 147
fissures, 141–142
fistula, 142–147, 143–144t
hemorrhoids, 140
skin tags, 139–140
stricture, 142
ulcerations, 140–141
complications of, 138
diagnosis of, 138
epidemiology of, 137–
138
manifestations,
137
P
erianal eczema/rash, 194
Perianal injury, 209–210
Perianal skin tag, 53
Perineal sensation assessment, 32
Petrolatum ointment, for pruritus ani, 117
Pharynx (phar yngeal gut), 1
Phenylephrine
for fecal incontinence, 171
for internal hemorrhoids, 56
Pilonidal disease
clinical manifestations of, 102
complications of, 103
differential diagnosis of, 102
etiology of, 101–102
incidence of, 101
pathologic anatomy of, 103
postoperative care of, 111
surgical treatment for, 104–111
biologic sealant, 111
conservative management, 110
cryosurgical ablation, 110
cutting seton, 111
excision and primary course, 106–107,
107f
excision and rotation flap, 108–110,
108–109f
excision with open wound, 104–105,
105f
incision and curettage, 105, 105f
laser depilation, 110
274 Index
Соседние файлы в папке Библиотека им академика М.И. Перельмана
